Platform Development (EVE16™ + targeted LNPs)
Undisclosed (Likely Oncology/Immunology)
Pre-clinicalActive
Key Facts
Indication
Undisclosed (Likely Oncology/Immunology)
Phase
Pre-clinical
Status
Active
Company
About InnDura Therapeutics
InnDura Therapeutics is an early-stage biotech focused on next-generation cell and gene therapies using in vivo mRNA delivery. Its core technology integrates targeted LNPs with the proprietary EVE16™ platform to reprogram immune cells directly within the patient's body, aiming for more effective and accessible immunotherapies. The company is pre-clinical and pre-revenue, operating as a private entity. Its location in Cambridge provides access to top-tier talent, capital, and research collaborators, positioning it to advance its platform toward clinical development.
View full company profileTherapeutic Areas
Other Undisclosed (Likely Oncology/Immunology) Drugs
| Drug | Company | Phase |
|---|---|---|
| Undisclosed BLA-Stage Asset | XOMA | BLA Submission |